Goserelin

Records for this ingredient, by country (identity only).

ATC L02AE03 · 9 markets · 60 records

Goserelin 9 markets · 60 records Forms
Filters
MarketGB 25AU 12CN 7HK 4JP 3US 2CA 2SG 2ES 2
Kind

GB 25 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

  • 3.6 mg per mL / per unit basis not statedinjectionNovgos 3.6mg implant pre-filled syringesZoladex 3.6mg implant SafeSystem pre-filled syringes、Manufacturer: A A H Pharmaceuticals Ltd
  • 10.8 mg per mL / per unit basis not statedinjectionZoladex LA 10.8mg implant SafeSystem pre-filled syringes

AU 12 records · 6 shown of 6 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

  • 10.8 mgimplantZoladex 10.8 also in US·CA
  • 3.6 mgimplantZoladex also in US·CA
  • 10.8 mgunknownZOLADEX 10.8 IMPLANT goserelin 10.8mg (as acetate) implant syringe unknown
  • 3.6 mgunknownZoladex Goserelin 3.6mg (as acetate) Implant syringe unknown

Combination products containing this ingredient

  • 10.8 mgtablet CombinationBicalutamide 50 mg + Goserelin 10.8 mgZolaCos CP 10.8/50(28)ZolaCos CP 10.8/50(84)、ZolaCos CP Combination Goserelin 3.6mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack unknown
  • 3.6 mgtablet CombinationBicalutamide 50 mg + Goserelin 3.6 mgZolaCos CP 3.6/50ZolaCos CP Combination Goserelin 3.6mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack unknown
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ZolaCos CP ×1Zoladex Implant ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CN 7 records · 3 shown of 3 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

Only this ingredient

  • 3.6 mg per mL / per unit basis not statedinjectionManufacturer: 山东绿叶制药有限公司
  • 10.8 mgother · extended-release诺雷得戈舍瑞林Manufacturer: AstraZeneca UKLimited
  • 3.6 mgother · extended-release诺雷得戈舍瑞林

HK 4 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名GOSERELIN ALVOGEN IMPLANT IN A PREFILLED SYRINGE 10.8MG ×4ZOLADEX DEPOT INJ 3.6MG ×1ZOLADEX LA DEPOT INJ 10.8MG ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 3 records · 3 shown of 3 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

Only this ingredient

  • 3.6 mg per mL / per unit basis not statedinjectionゾラデックス3.6mgデポ
  • 10.8 mg per mL / per unit basis not statedinjectionゾラデックスLA10.8mgデポ
  • 1.8 mg per mL / per unit basis not statedinjectionゾラデックス1.8mgデポ

US 2 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

  • 10.8 mg/syringe per mL / per unit basis not statedinjectionZOLADEX LA DEPOT INJECTION 10.8 mg/syringe
  • 3.6 mg/syringe per mL / per unit basis not statedinjectionZOLADEX DEPOT INJECTION 3.6 mg/syringe

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

Only this ingredient

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.